Summary Information:
Evoke Pharma Inc. Common Stock
NASDAQ:EVOK


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Evoke Pharma Inc. Common Stock
Exchange: NASDAQ
Symbol: EVOK
SEC CIK: 0001403708
Phone: 858-345-1494
420 STEVENS AVENUE
SUITE 370
SOLANA BEACH CA 92075
CEO: David Gonyer
Price when page updated: 1.285 Date: 2023-11-30
Company Website:
www.evokepharma.com

_Description: Evoke is a specialty pharmaceutical company focused primarily on the commercialization and development of drugs to treat GI disorders and diseases. The Company developed GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.

IPO YEAR:
2013
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
4295845.00
Beta:
-0.0951710655312804
52 Week High:
4.8
52 Week Low:
0.508
52 Week Change:
-0.7758007117437722
Short Interest:

Short Date:

Shares Outstanding:
32656480
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
10 Nov 2022
Float:
0
return on Equity:
-
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
$2.171M
Gross Profit:

Cash:

Debt:

Institution Percent:
4.80%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
2.46%
Return on Assets:
-
Return on Capital:

Profit Margin:
-
Price to Sales:
5.00
Price To Book:
18.97
Short Ratio:
0.04
PE Ratio:
0
Employees:
5
1Y Guesstimate
25.648:7.0:6




__The following are links to various summary and news pages for
__Evoke Pharma Inc. Common Stock [ EVOK ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30